Caption Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170M Buy
1,347,600
+1,147,600
+574% +$151M 0.79% 19
2026
Q1
$27.9M Buy
200,000
+100,000
+100% +$14M 0.16% 129
2025
Q4
$12.3M Buy
100,000
+70,000
+233% +$8.51M 0.08% 283
2025
Q3
$3.33M Sell
30,000
-340,000
-92% -$38.6M 0.03% 636
2025
Q2
$41M Buy
+370,000
New +$39.4M 0.45% 29
2024
Q1
Sell
-18,400
Closed -$1.49M 1372
2023
Q4
$1.49M Buy
+18,400
New +$1.43M 0.02% 698
2022
Q4
Sell
-113,900
Closed -$7.03M 1423
2022
Q3
$7.03M Sell
113,900
-39,600
-26% -$2.5M 0.1% 254
2022
Q2
$9.49M Buy
153,500
+130,000
+553% +$8.05M 0.13% 202
2022
Q1
$1.4M Hold
23,500
0.02% 859
2021
Q4
$1.71M Sell
23,500
-65,000
-73% -$4.48M 0.02% 844
2021
Q3
$6.18M Buy
88,500
+35,000
+65% +$2.46M 0.07% 368
2021
Q2
$3.68M Buy
+53,500
New +$3.57M 0.05% 467
2019
Q4
Sell
-50,000
Closed -$3.17M 905
2019
Q3
$3.17M Buy
+50,000
New +$3.27M 0.16% 169

Other funds holding GILD

Caption Management's GILD Position: Q2 2026 in Review

Caption Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 100,000 shares worth $12.6M. The stake represents 0.06% of the portfolio and ranks #338 among its holdings. This is a return to the name: Caption Management previously reported a position in GILD as recently as Q3 2025.

Caption Management first reported a position in GILD in Q3 2019 and has held it in 10 quarters since. The position peaked at $16.5M in Q2 2025. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Caption Management held 100,000 shares of Gilead Sciences worth $12.6M as of Q2 2026.
  • Gilead Sciences was a new Caption Management position in Q2 2026.
  • Gilead Sciences made up 0.06% of Caption Management's portfolio in Q2 2026, its #338 holding.
  • Caption Management first reported a position in Gilead Sciences in Q3 2019 and has held it in 10 quarters since.
  • Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.